GD vs TERN · P/E 22, rev $52.55B vs $6.12B cap
General Dynamics Corporation (GD) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
General Dynamics Corporation (GD) is a aerospace & defense company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported GD revenue for 2025-12-31 was $52.55B. Net income was $4.21B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. GD currently screens at market cap $93.69B and trailing P/E 21.8.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
GD currently screens at market cap $93.69B and trailing P/E 21.8. TERN currently screens at market cap $6.12B.
Not investment advice. Open the GD and TERN stock pages for the full models.
Not investment advice.